Co-treatment with heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin (DMAG) and vorinostat: a highly active combination against human mantle cell lymphoma (MCL) cells.

Co-treatment with heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin (DMAG) and vorinostat: a highly active combination against human mantle cell lymphoma (MCL) cells. Cancer Biol Ther. 2009 Jul; 8(13):1273-80.

View in: PubMed

subject areas

Acetylation
Apoptosis
Benzoquinones
Blotting, Western
Cell Cycle
Cell Cycle Proteins
Cell Line, Tumor
Cell Survival
Cells, Cultured
Dose-Response Relationship, Drug
Drug Synergism
G1 Phase
G2 Phase
HSP90 Heat-Shock Proteins
Humans
Hydroxamic Acids
Lactams, Macrocyclic
Lymphoma, Mantle-Cell
Tumor Cells, Cultured

authors with profiles

WARREN C FISKUS
KAPIL BHALLA